Skip to main content
Clinical Trials/NCT06054945
NCT06054945
Completed
Not Applicable

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block in Knee Arthroplasty Patients Under Spinal Anesthesia: A Retrospective Cohort Study

Samsun University1 site in 1 country88 target enrollmentSeptember 3, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Analgesia
Sponsor
Samsun University
Enrollment
88
Locations
1
Primary Endpoint
Opioid consumption
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In our clinic, routine suprainguinal fascia iliaca block (SIFIB) has been administered for postoperative analgesia in patients undergoing knee arthroplasty. Recently, we have introduced the IPACK (Infiltration between the Popliteal Artery and Capsule of the Knee) block to this regimen, and the aim of this retrospective study is to determine whether the addition of the IPACK block enhances the quality of analgesia.

Knee arthroplasty, also known as knee joint replacement surgery, is a common procedure performed to alleviate pain and improve joint function in patients with knee osteoarthritis or other knee-related conditions. Postoperative pain management is crucial for patient comfort and overall recovery.

In this study, we aimed to compare the two techniques mentioned earlier, namely the SIFIB (Suprainguinal Fascia Iliaca Block) and the SIFIB+IPACK, by examining the data of patients who underwent knee arthroplasty under spinal anesthesia at our clinic between January 1, 2023, and September 1, 2023.

Registry
clinicaltrials.gov
Start Date
September 3, 2023
End Date
September 15, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Samsun University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients meeting the following criteria and whose postoperative follow-up forms were completed in full were included in the study
  • Patients underwent total knee arthroplasty (TKA)
  • ASA class I to III.
  • operated under spinal anesthesia
  • patient controlled analjgesia device was used for analgesia

Exclusion Criteria

  • Patients whose data were inaccessible or had incomplete follow-up forms were excluded from the study to ensure the accuracy and reliability of our analysis.
  • PCA device problems in follow up in 24 hours
  • anesthesia plans were converted to general anesthesia
  • spinal anesthesia failure
  • peripheral blocks used other than protocol

Outcomes

Primary Outcomes

Opioid consumption

Time Frame: 24 hours

Opioid consumption via PCA device

Secondary Outcomes

  • NRS scores(24 hours)

Study Sites (1)

Loading locations...

Similar Trials